Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report)’s stock price was down 3.2% during trading on Friday after an insider sold shares in the company. The business has a 50 day moving average price of $16.44 and a 200-day moving average price of $15.06. Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report) last issued its earnings results on Wednesday, August 6th. Arcutis Biotherapeutics Company Profile(Get Free Report)Arcutis Biotherapeutics, Inc, a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Recommended StoriesReceive News & Ratings for Arcutis Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcutis Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.